Dianthus Therapeutics CFO Sells $9.5 Million in Stock
This biotech firm developing antibody therapies for rare diseases disclosed a significant insider sale amid rapid share price gains.
Source: www.fool.com
This biotech firm developing antibody therapies for rare diseases disclosed a significant insider sale amid rapid share price gains.